April 24, 2018 4:50 PM ET

Pharmaceuticals

Company Overview of Xanodyne Pharmaceuticals, Inc.

Company Overview

Xanodyne Pharmaceuticals, Inc. develops and commercializing products in women’s healthcare and pain management in the United States. Its product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company also promotes Duet line of prescription prenatal vitamins; and Oramorph SR, which is a sustained release morphine oral tablet for the relief of pain in patients who require opioid analgesics, as well as markets over-the-counte...

One Riverfront Place

Newport, KY 41071

United States

Founded in 2000

179 Employees

Phone:

859-371-6383

Fax:

859-371-6391

Key Executives for Xanodyne Pharmaceuticals, Inc.

Chief Regulatory Officer, Corporate Secretary and General Counsel
Age: 55
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
Praetego, Inc. United States
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Xanodyne Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.